Browning, Michael. editor. edt http://id.loc.gov/vocabulary/relators/edt Cowen, Philip J. editor. edt http://id.loc.gov/vocabulary/relators/edt Sharp, Trevor. editor. edt http://id.loc.gov/vocabulary/relators/edt SpringerLink (Online service) text sz 2024 1st ed. 2024. monographic eng

electronic

electronic resource

access X, 311 p. 100 illus., 30 illus. in color. online resource. This volume is unique in bringing the exciting range of antidepressant treatment developments together with a focus on their neurobiological mechanisms and how these interact with the known pathophysiology of depression. Current evidence for treatment efficacy is reviewed together with a discussion of where in the management pathway of this common condition, these new approaches might take their place. SSRIs A pharmacological cul-de-sac -- Neurobiology of SSRI withdrawal -- Pramipexole in the treatment of depression -- Opioid mechanisms in the treatment of depression -- Neuropsychological effects of antidepressants-translational studies -- KETAMINE FOR MAJOR DEPRESSIVE DISORDER -- Psilocybin and other classic psychedelics in depression -- Gut-brain axis and antidepressant treatment -- Anti-inflammatory drugs in the treatment of depression -- Mechanisms of TMS in Depression -- Mechanism of action of ECT in depression -- Vagal nerve stimulation in the treatment of depression. edited by Michael Browning, Philip J. Cowen, Trevor Sharp. Psychobiology Human behavior Neuropharmacology Psychiatry Behavioral Neuroscience Neuropharmacology Psychiatry QP360-360.7 9783031663567 https://doi.org/10.1007/978-3-031-66356-7 https://doi.org/10.1007/978-3-031-66356-7 240725 20251030112650.0 978-3-031-66356-7